205
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Blood suPAR, Th1 and Th17 cell may serve as potential biomarkers for elderly sepsis management

, , , , & ORCID Icon
Pages 488-493 | Received 04 Feb 2021, Accepted 03 Jul 2021, Published online: 07 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (4)

Xi Chen, Xia Chen, Yingxue Yang, Na Luo, Jian Yang, Lingui Zhong, Tingting Guo, Zhongzhen Yuan, Qiang Wei & Chuanjiang Wang. (2023) Protective role of the novel cytokine Metrnl/ interleukin-41 in host immunity defense during sepsis by promoting macrophage recruitment and modulating Treg/Th17 immune cell balance. Clinical Immunology 254, pages 109690.
Crossref
Yane Wang, Zhimin Liu, Mengli Zhang, Bo Yu & Fen Ai. (2023) Mucosa-associated lymphoid tissue lymphoma translocation protein 1 exaggerates multiple organ injury, inflammation, and immune cell imbalance by activating the NF-κB pathway in sepsis. Frontiers in Microbiology 14.
Crossref
Feng Geng, Wei Liu & Li Yu. (2022) MicroRNA-451a and Th1/Th2 ratio inform inflammation, septic organ injury, and mortality risk in sepsis patients. Frontiers in Microbiology 13.
Crossref
Alexi Vasbinder, Elizabeth Anderson, Husam Shadid, Hanna Berlin, Michael Pan, Tariq U. Azam, Ibrahim Khaleel, Kishan Padalia, Chelsea Meloche, Patrick O’Hayer, Erinleigh Michaud, Tonimarie Catalan, Rafey Feroze, Pennelope Blakely, Christopher Launius, Yiyuan Huang, Lili Zhao, Lynn Ang, Monica Mikhael, Kara Mizokami-Stout, Subramaniam Pennathur, Matthias Kretzler, Sven H. Loosen, Athanasios Chalkias, Frank Tacke, Evangelos J. Giamarellos-Bourboulis, Jochen Reiser, Jesper Eugen-Olsen, Eva L. Feldman, Rodica Pop-Busui & Salim S. Hayek. (2022) Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19. Diabetes Care 45:3, pages 692-700.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.